Ion Cristóbal

SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia

Ion Cristóbal, Francisco J. Blanco, Laura García-Ortí et al. · Blood · 2009 · 178 citations

miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation

Valentina Boni, Nerea Bitarte, Ion Cristóbal et al. · Molecular Cancer Therapeutics · 2010 · 156 citations · Full text

Tumor Biology, Systems Biology, Fluoropyrimidine Response +15

PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect

Ion Cristóbal, Laura García-Ortí, Cristina Cirauqui et al. · Leukemia · 2011 · 136 citations

Hematological Malignancy, Signal Transduction, Common Event +13

PP2A Inhibition Is a Common Event in Colorectal Cancer and Its Restoration Using FTY720 Shows Promising Therapeutic Potential

Ion Cristóbal, Rebeca Manso, Raúl Rincón et al. · Molecular Cancer Therapeutics · 2014 · 124 citations · Full text

Tumor Biology, Oncology, Chemoprevention Strategy +11

Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia

Ion Cristóbal, Laura García-Ortí, Cristina Cirauqui et al. · Haematologica · 2011 · 119 citations · Full text